Umbilical cord as a source of immunomodulatory reagents

Antonio Galleu*, Francesco Dazzi

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    1 Citation (Scopus)

    Abstract

    One of the main successes of cellular therapies in the last decade has been the generation of immunomodulating reagents for clinical use. Umbilical cord can be used to source such cell populations. In this chapter we will concentrate on describing the features of and the clinical experience with regulatory T-cells and mesenchymal stromal cells. Although relevant immunomodulating activity can also be ascribed to hematopoietic stem cells, that is the subject of another chapter of this book. Similarly, other populations have been isolated and demonstrated to exhibit immunosuppressive activity but, probably because of their small concentration and the difficulty in their expansion, they have not been developed any further.

    Original languageEnglish
    Title of host publicationCord Blood Stem Cells Medicine
    PublisherELSEVIER ACADEMIC PRESS INC
    Pages125-140
    Number of pages16
    ISBN (Print)9780124078369, 9780124077850
    DOIs
    Publication statusPublished - 10 Dec 2014

    Keywords

    • Cellular Therapy
    • Graft-versus-Host-Disease
    • Mesenchymal Stromal Cells
    • Regulatory T-cells
    • Umbilical cord blood and tissue

    Fingerprint

    Dive into the research topics of 'Umbilical cord as a source of immunomodulatory reagents'. Together they form a unique fingerprint.

    Cite this